ArticleBrazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]2025
Molecular docking targeting biofilm and quorum sensing modulation: antimicrobial potential of Salsola tragus.
Article in Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology], 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study explores the antimicrobial properties and molecular docking analysis of compounds derived from Salsola tragus, highlighting their potential as bioactive agents. The antimicrobial activity of the ethanol extract of S. tragus was assessed against a range of bacterial and yeast strains using the microdilution method. The results revealed significant inhibitory effects, with Minimum Inhibitory Concentration (MIC) values ranging from < 6.25 to > 50 mg/mL, indicating that the extract possesses considerable antimicrobial efficacy. Additionally, the extract demonstrated substantial biofilm inhibition against biofilm-forming strains of Pseudomonas aeruginosa, reducing biofilm formation concentration-dependently. Molecular docking studies were performed to predict the interaction between the bioactive compounds of S. tragus and the LasR-OC12 HSL complex of Pseudomonas aeruginosa (PDB ID: 3IX3). Key compounds such as 1,8-Diazacyclotetradecane-2,7-dione, phytane, ethyl oleate, and linoleic acid ethyl ester displayed notable binding affinities, with 1,8-Diazacyclotetradecane-2,7-dione exhibiting the highest binding affinity (-5.7 kcal/mol) and lowest inhibition constant (0.066 mM), suggesting strong interaction with the target protein. The study also assessed the toxicity profiles of these compounds, indicating varying levels of acute toxicity and bioavailability, with most compounds showing low toxicity and favorable pharmacological profiles. Overall, this study demonstrates the potential of S. tragus extract as a source of antimicrobial agents capable of interfering with microbial growth and biofilm formation, along with promising molecular interactions, as indicated by docking studies. Further investigation is warranted to optimize these properties for potential therapeutic applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.